We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
- Authors
Liu, Congxing; Witt, Lydia; Ianes, Chiara; Bischof, Joachim; Bammert, Marie-Thérèse; Baier, Joana; Kirschner, Stefan; Henne-Bruns, Doris; Xu, Pengfei; Kornmann, Marko; Peifer, Christian; Knippschild, Uwe
- Abstract
Protein kinases of the CK1 family can be involved in numerous physiological and pathophysiological processes. Dysregulated expression and/or activity as well as mutation of CK1 isoforms have previously been linked to tumorigenesis. Among all neoplastic diseases, colon and rectal cancer (CRC) represent the fourth leading cause of cancer related deaths. Since mutations in CK1δ previously found in CRC patients exhibited increased oncogenic features, inhibition of CK1δ is supposed to have promising therapeutic potential for tumors, which present overexpression or mutations of this CK1 isoform. Therefore, it is important to develop new small molecule inhibitors exhibiting higher affinity toward CK1δ mutants. In the present study, we first characterized the kinetic properties of CK1δ mutants, which were detected in different tumor entities. Subsequently, we characterized the ability of several newly developed IWP-based inhibitors to inhibit wild type and CK1δ mutants and we furthermore analyzed their effects on growth inhibition of various cultured colon cancer cell lines. Our results indicate, that these compounds represent a promising base for the development of novel CRC therapy concepts.
- Subjects
COLON cancer; CELL lines; CANCER cells; PROTEIN kinases; SMALL molecules
- Publication
International Journal of Molecular Sciences, 2019, Vol 20, Issue 24, p6184
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms20246184